Hodgkin Lymphoma Latest Advances

Vanishing bile duct syndrome in relapsed classic Hodgkin lymphoma: treatment considerations and outcomes.

Journal: BMJ case reports

Published: June 23, 2026

Outcomes of Acute Ischemic Stroke in Patients with Hematological Malignancies.

Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques

Published: June 22, 2026

Hodgkin lymphoma treatment patterns and outcome disparities in low- and middle-income countries.

Journal: Blood global hematology

Published: June 19, 2026

Diefenbach CS, Jegede O, Wang V, et al. A randomized phase 2 study of ipilimumab, nivolumab, and brentuximab vedotin in patients with relapsed Hodgkin lymphoma. Blood. 2026;147(18):2041-2052.

Journal: Blood

Published: June 18, 2026

Immunogenomic profiles of HIV-associated classic Hodgkin lymphoma from Malawi.

Journal: Blood global hematology

Published: June 17, 2026

Advances in Pediatric Hodgkin Lymphoma with an Eye on Disparities and Vulnerable Populations.

Journal: Hematology/oncology clinics of North America

Published: June 10, 2026

Microcosting of Childhood Hodgkin Lymphoma Treatment Across Resource Levels Using the Adapted Resource and Implementation Application Guidelines in the US.

Journal: JCO global oncology

Published: June 10, 2026

Revisiting multi-nodal radiomics with advanced feature learning for lymphoma classification: a multi-center study.

Journal: Physics in medicine and biology

Published: June 05, 2026

Genetic risk and immune dysregulation of classic Hodgkin lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma: a multicentric study.

Journal: medRxiv : the preprint server for health sciences

Published: June 04, 2026

Cutaneous-predominant Hodgkin's lymphoma

Journal: La Revue du praticien

Published: June 02, 2026

Early Intensification with bendamustine supercharge plus brentuximab vedotinfollowing failure to obtain complete metabolic remission after two cycles of ABVD inpatients aged ≤60 years with classic Hodgkin lymphoma. Comment on:"Brentuximab-vedotin and bendamustine for relapsed or refractory Hodgkinlymphoma: the LYSA real-world experience".

Journal: Haematologica

Published: May 30, 2026

Improving salvage regimens prior to autologous stem cell transplantation in relapsed/refractory Hodgkin's lymphoma patients: updates in the novel therapy era.

Journal: Expert review of hematology

Published: May 30, 2026

Hodgkin Lymphoma Latest Advances

Find the Latest Research About Hodgkin Lymphoma

Vanishing bile duct syndrome in relapsed classic Hodgkin lymphoma: treatment considerations and outcomes.

Vanishing bile duct syndrome in relapsed classic Hodgkin lymphoma: treatment considerations and outcomes.

Outcomes of Acute Ischemic Stroke in Patients with Hematological Malignancies.

Outcomes of Acute Ischemic Stroke in Patients with Hematological Malignancies.

Hodgkin lymphoma treatment patterns and outcome disparities in low- and middle-income countries.

Hodgkin lymphoma treatment patterns and outcome disparities in low- and middle-income countries.

Diefenbach CS, Jegede O, Wang V, et al. A randomized phase 2 study of ipilimumab, nivolumab, and brentuximab vedotin in patients with relapsed Hodgkin lymphoma. Blood. 2026;147(18):2041-2052.

Diefenbach CS, Jegede O, Wang V, et al. A randomized phase 2 study of ipilimumab, nivolumab, and brentuximab vedotin in patients with relapsed Hodgkin lymphoma. Blood. 2026;147(18):2041-2052.

Immunogenomic profiles of HIV-associated classic Hodgkin lymphoma from Malawi.

Immunogenomic profiles of HIV-associated classic Hodgkin lymphoma from Malawi.

Advances in Pediatric Hodgkin Lymphoma with an Eye on Disparities and Vulnerable Populations.

Advances in Pediatric Hodgkin Lymphoma with an Eye on Disparities and Vulnerable Populations.

Microcosting of Childhood Hodgkin Lymphoma Treatment Across Resource Levels Using the Adapted Resource and Implementation Application Guidelines in the US.

Microcosting of Childhood Hodgkin Lymphoma Treatment Across Resource Levels Using the Adapted Resource and Implementation Application Guidelines in the US.

Revisiting multi-nodal radiomics with advanced feature learning for lymphoma classification: a multi-center study.

Revisiting multi-nodal radiomics with advanced feature learning for lymphoma classification: a multi-center study.

Genetic risk and immune dysregulation of classic Hodgkin lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma: a multicentric study.

Genetic risk and immune dysregulation of classic Hodgkin lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma: a multicentric study.

Cutaneous-predominant Hodgkin's lymphoma

Cutaneous-predominant Hodgkin's lymphoma

Improving salvage regimens prior to autologous stem cell transplantation in relapsed/refractory Hodgkin's lymphoma patients: updates in the novel therapy era.

Improving salvage regimens prior to autologous stem cell transplantation in relapsed/refractory Hodgkin's lymphoma patients: updates in the novel therapy era.